SCHEDULE: FMR LLC Discloses 15% Stake in Galecto, Inc.
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have reported a 15.0% beneficial ownership stake in Galecto, Inc., totaling 238,878 shares of common stock.
Summary
- FMR LLC and Abigail P. Johnson beneficially own 238,878 shares of Galecto, Inc. common stock.
- This represents 15.0% of Galecto, Inc.'s outstanding common stock.
- The percentage is based on 1,592,521 shares outstanding, which includes 1,327,212 shares as of November 7, 2025, and an additional 265,309 shares issued in connection with a merger.
- FMR LLC holds sole voting and dispositive power over all 238,878 shares.
- Abigail P. Johnson also holds sole dispositive power over the same 238,878 shares.
- Select Health Care Portfolio is known to have the right to receive dividends or proceeds from 160,000 shares, representing 10.0% of the total outstanding common stock as of November 28, 2025.
- Fidelity Management & Research Company LLC, an investment adviser, is identified as a relevant entity beneficially owning shares.
Sentiment
Score: 6
Explanation: The filing is neutral in nature, primarily a disclosure of beneficial ownership. The presence of a significant institutional investor like FMR LLC can be seen as a positive signal, but the filing itself contains no operational or financial performance data to warrant a higher score.
Positives
- A significant institutional investor, FMR LLC, has disclosed a substantial 15.0% stake in Galecto, Inc., indicating confidence in the company.
- The filing confirms the beneficial ownership is held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of a significant ownership stake by a major investment management firm, FMR LLC, in a publicly traded company, Galecto, Inc. It reflects an investment decision rather than an operational update or industry trend analysis from the issuer's perspective.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by FMR LLC could be viewed positively, potentially increasing investor confidence and liquidity.
- Employees, Customers, Suppliers, Creditors: No direct impact is indicated by this ownership disclosure.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC signatory. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC where Power of Attorney was incorporated by reference. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson signatory. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's Power of Attorney was incorporated by reference. |
| 2025-11-07 | Date of 1,327,212 shares outstanding as reported in Exhibit 2.1 to the Issuer's Current Report on Form 8-K. |
| 2025-11-10 | Date of filing of Issuer's Current Report on Form 8-K disclosing Agreement and Plan of Merger. |
| 2025-11-28 | Date of event which requires filing of this statement; also the date for Select Health Care Portfolio's interest calculation. |
| 2025-12-04 | Date of agreement for joint filing of Schedule 13G. |
Recommendation
holdThis Schedule 13G filing primarily serves as a disclosure of a significant beneficial ownership stake by FMR LLC and Abigail P. Johnson in Galecto, Inc. While the presence of a major institutional investor can be a positive signal, the filing itself does not provide sufficient operational or financial data to warrant a 'buy' or 'sell' recommendation. It simply confirms a substantial passive investment. Investors should 'hold' and await further operational or financial updates from Galecto, Inc. to make a more informed decision.
Keywords
Galecto Inc, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investment, equity stake, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.